ACQUIREDT+30
Aim Immunotech Inc · NASDAQ
+24,000 sh · $5.0K
Filed 18 Sept 2026SEC Form 4view source
- ACQUIREDT+30
Aim Immunotech Inc · NASDAQ
+11,000 sh · $2.3K
Filed 17 Sept 2026SEC Form 4view source - ACQUIREDT+30
Aim Immunotech Inc · NASDAQ
+22,000 sh · $4.9K
Filed 16 Sept 2026SEC Form 4view source - ACQUIREDT+30
Aim Immunotech Inc · NASDAQ
+5,900 sh · $1.3K
Filed 15 Sept 2026SEC Form 4view source